(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examp...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/3/39 |
id |
doaj-88dce6cba3d548238e90feb16ba6357b |
---|---|
record_format |
Article |
spelling |
doaj-88dce6cba3d548238e90feb16ba6357b2020-11-25T03:50:46ZengMDPI AGPharmaceuticals1424-82472020-03-011333910.3390/ph13030039ph13030039(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast CancerIrina Velikyan0Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, 751 83 Uppsala, SwedenThe role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examples of targeted (radio)pharmaceuticals for the imaging and therapy of neuroendocrine neoplasms (NENs), prostate cancer, and breast cancer. These examples strongly demonstrate the tendency of nuclear medicine development towards personalized medicine.https://www.mdpi.com/1424-8247/13/3/39(radio)theranosticssomatostatinneuroendocrine neoplasmsprostate cancerbreast cancerpsmapetspectgallium-68lutetium-177 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Irina Velikyan |
spellingShingle |
Irina Velikyan (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer Pharmaceuticals (radio)theranostics somatostatin neuroendocrine neoplasms prostate cancer breast cancer psma pet spect gallium-68 lutetium-177 |
author_facet |
Irina Velikyan |
author_sort |
Irina Velikyan |
title |
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer |
title_short |
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer |
title_full |
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer |
title_fullStr |
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer |
title_full_unstemmed |
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer |
title_sort |
(radio)theranostic patient management in oncology exemplified by neuroendocrine neoplasms, prostate cancer, and breast cancer |
publisher |
MDPI AG |
series |
Pharmaceuticals |
issn |
1424-8247 |
publishDate |
2020-03-01 |
description |
The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examples of targeted (radio)pharmaceuticals for the imaging and therapy of neuroendocrine neoplasms (NENs), prostate cancer, and breast cancer. These examples strongly demonstrate the tendency of nuclear medicine development towards personalized medicine. |
topic |
(radio)theranostics somatostatin neuroendocrine neoplasms prostate cancer breast cancer psma pet spect gallium-68 lutetium-177 |
url |
https://www.mdpi.com/1424-8247/13/3/39 |
work_keys_str_mv |
AT irinavelikyan radiotheranosticpatientmanagementinoncologyexemplifiedbyneuroendocrineneoplasmsprostatecancerandbreastcancer |
_version_ |
1724490705419632640 |